New patent for Ocuphire drug RYZUMVI

Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…

The post New patent for Ocuphire drug RYZUMVI appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog